Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
86.73%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 5.8Close
$ 4.78 - $ 13.59 52-Week Range
Ticker Information
Ticker
BOLTCompany Name
BOLT BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBOLT BIOTHERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BOLT - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 4.17M | $ 3.61M | 86.73% |
| 3/31/2025 | $ 3.64M | $ 5.81M | 159.81% |
| 12/31/2024 | $ 7.69M | $ 7.41M | 96.32% |
| 9/30/2024 | $ 9.78M | $ 8.29M | 84.8% |
| 6/30/2024 | $ 11.17M | $ 9.52M | 85.29% |
| 3/31/2024 | $ 11.32M | $ 9.05M | 79.91% |
| 12/31/2023 | $ 7.88M | $ 9.22M | 117.1% |
| 9/30/2023 | $ 7.2M | $ 9.28M | 128.9% |
| 6/30/2023 | $ 6.78M | $ 9.09M | 134.06% |
| 3/31/2023 | $ 6.74M | $ 9.13M | 135.46% |
Key Performance Insights, Last 5 Years
- BOLT BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 614.72%.
- Over the past 5 years, BOLT BIOTHERAPEUTICS INC's average SB Comp % has been 259.6%.
- The median SB Comp % for BOLT BIOTHERAPEUTICS INC during this period was 135.46%
- BOLT BIOTHERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 921.14%.
- The lowest SB Comp % recorded by BOLT BIOTHERAPEUTICS INC in the same timeframe 79.91%
BOLT BIOTHERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for BOLT BIOTHERAPEUTICS INC is calculated as follows: SB Comp. [ $ 1.42M ] / Revenues [ $ 231K ]
(=) SB Comp % [ 614.72% ] BOLT - Stock Based Compensation Margin, Last 5 years
79.91%
Minimum
Mar 31, 2024
921.14%
Maximum
Sep 30, 2021
259.6%
Average
135.46%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |